Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapy.

Sara Nysom Christiansen Mikkel Østergaard Ole SlotHelen KeenGeorge A W BruynMaria Antonietta D'Agostino Lene Terslev

Published in: RMD open (2021)

Ultrasound assessment of the OMERACT structural gout lesions scored binarily seems to be a useful tool for monitoring urate depositions during ULT. Particularly DC and tophus showed sensitivity to change after only 3 months of treatment.

Keyphrases

magnetic resonance imaging
uric acid
contrast enhanced ultrasound
computed tomography
immune response
replacement therapy
chemotherapy induced